"United Hospital Center is designed around the environment with the patient, family, staff and community in mind. The new UHC opened in 2010 and is located along I-79 in Bridgeport. The 692,000 square foot structure rises eight stories. It is designed around the environment with the patient, family, staff and community in mind—which includes enhanced patient privacy, a high level of technology integration and improved access to care. The acute care facility has 292 private inpatient rooms and 24 observation rooms with a medical staff that consist of more than 140 primary care and specialty physicians. UHC employs more than 2,000 Associates."

During the past decade, United Hospital Center conducted 58 clinical trials. In the 10-year time frame, 58 clinical trials started and 21 clinical trials were completed, i.e. on average, 36.2% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 20 clinical trials were completed. i.e. 142.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "United Hospital Center" #1 sponsor was "National Cancer Institute (NCI)" with 30 trials, followed by "SWOG Cancer Research Network" with 15 trials sponsored, "Alliance for Clinical Trials in Oncology" with 13 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 6 trials sponsored and "NRG Oncology" with 6 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "United Hospital Center" #1 collaborator was "National Cancer Institute (NCI)" with 43 trials as a collaborator, "NRG Oncology" with 7 trials as a collaborator, "Canadian Cancer Trials Group" with 5 trials as a collaborator, "Cancer and Leukemia Group B" with 2 trials as a collaborator and "Genentech, Inc." with 2 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "United Hospital Center" are "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "Breast Cancer" (4 trials), "Stage IIIA Breast Cancer" (4 trials) and "Colorectal Cancer" (3 trials). Many other conditions were trialed in "United Hospital Center" in a lesser frequency.

Most popular intervention types in "United Hospital Center" are "Drug" (55 trials), "Other" (53 trials), "Biological" (36 trials), "Procedure" (25 trials) and "Radiation" (11 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (27 trials), "Quality-of-Life Assessment" (23 trials), "Computed Tomography" (14 trials), "Nivolumab" (14 trials) and "Biospecimen Collection" (11 trials). Other intervention names were less common.

The vast majority of trials in "United Hospital Center" are 64 trials for "All" genders, 10 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "United Hospital Center". undefined are not yet recruiting, 20 are recruiting, 35 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in United Hospital Center, 3 suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in United Hospital Center, 1 "Phase 1" clinical trials were conducted, 28 "Phase 2" clinical trials and 48 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".